Skandigen Interim report January - June 1996

Skandigen Interim report January - June 1996 - The Group's sales amounted to MSEK 10.5 (1.6) for the period. The consolidated result after depreciation was MSEK -2.4 (-8.2). The result after net financial items amounted to MSEK 8.4 (-8.6). The net financial items include a non-recurring revenue from the sale of subscription warrants of MSEK 10.2 (0). - The part-owned company SIBIA Neurosciences, Inc. completed a 2.1 million share initial public offering which, together with a private placement to CIBA-GEIGY Limited (Novartis), raised gross proceeds over USD 28 million for SIBIA. The stock is quoted on Nasdaq since May 10. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net